These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1010 related articles for article (PubMed ID: 14759339)

  • 41. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays.
    Jenner RG; Albà MM; Boshoff C; Kellam P
    J Virol; 2001 Jan; 75(2):891-902. PubMed ID: 11134302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel monoclonal antibodies for identification of multicentric Castleman's disease; Kaposi's sarcoma-associated herpesvirus-encoded vMIP-I and vMIP-II.
    Nakano K; Katano H; Tadagaki K; Sato Y; Ohsaki E; Mori Y; Yamanishi K; Ueda K
    Virology; 2012 Apr; 425(2):95-102. PubMed ID: 22297135
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease.
    Katano H; Sato Y; Kurata T; Mori S; Sata T
    Virology; 2000 Apr; 269(2):335-44. PubMed ID: 10753712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation.
    Arvanitakis L; Geras-Raaka E; Varma A; Gershengorn MC; Cesarman E
    Nature; 1997 Jan; 385(6614):347-50. PubMed ID: 9002520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator.
    Chen J; Ueda K; Sakakibara S; Okuno T; Parravicini C; Corbellino M; Yamanishi K
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4119-24. PubMed ID: 11274437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Notch signal transduction induces a novel profile of Kaposi's sarcoma-associated herpesvirus gene expression.
    Chang H
    J Microbiol; 2006 Apr; 44(2):217-25. PubMed ID: 16728959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of cell signaling pathways by Kaposi's sarcoma-associated herpesvirus (KSHVHHV-8).
    Damania B
    Cell Biochem Biophys; 2004; 40(3):305-22. PubMed ID: 15211030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Posttranscriptional gene regulation in Kaposi's sarcoma-associated herpesvirus.
    Conrad NK
    Adv Appl Microbiol; 2009; 68():241-61. PubMed ID: 19426857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SIV-positive and SIV-negative rhesus macaques.
    Renne R; Dittmer D; Kedes D; Schmidt K; Desrosiers RC; Luciw PA; Ganem D
    J Med Primatol; 2004 Feb; 33(1):1-9. PubMed ID: 15061726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human herpesvirus 8 infections in patients with immunodeficiencies.
    Laurent C; Meggetto F; Brousset P
    Hum Pathol; 2008 Jul; 39(7):983-93. PubMed ID: 18570975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
    Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes.
    Gao SJ; Zhang YJ; Deng JH; Rabkin CS; Flore O; Jenson HB
    J Infect Dis; 1999 Nov; 180(5):1466-76. PubMed ID: 10515805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p53 inhibition by the LANA protein of KSHV protects against cell death.
    Friborg J; Kong W; Hottiger MO; Nabel GJ
    Nature; 1999 Dec 23-30; 402(6764):889-94. PubMed ID: 10622254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. KSHV Genome Replication and Maintenance in Latency.
    Ueda K
    Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein.
    Lukac DM; Renne R; Kirshner JR; Ganem D
    Virology; 1998 Dec; 252(2):304-12. PubMed ID: 9878608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human herpesvirus 8 and angiosarcoma: analysis of 40 cases and review of the literature.
    Schmid H; Zietz C
    Pathology; 2005 Aug; 37(4):284-7. PubMed ID: 16194826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absence of Kaposi's sarcoma associated herpesvirus-like DNA sequences (KSHV) in HIV-negative multicentric Castleman's disease complicated by KSHV-positive Kaposi's sarcoma.
    Kwong YL; Chan AC
    Br J Haematol; 1997 Mar; 96(4):881-2. PubMed ID: 9074443
    [No Abstract]   [Full Text] [Related]  

  • 58. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.
    Cotter MA; Robertson ES
    Virology; 1999 Nov; 264(2):254-64. PubMed ID: 10562490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes.
    Direkze S; Laman H
    Int J Exp Pathol; 2004 Dec; 85(6):305-19. PubMed ID: 15566428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi's sarcoma-associated virus.
    Sun Y; Huang PL; Li JJ; Huang YQ; Zhang L; Huang PL; Lee-Huang S
    Biochem Biophys Res Commun; 2001 Oct; 287(4):983-94. PubMed ID: 11573962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.